Cancer immunomics: using autoantibody signatures in the early detection of prostate cancer.
about
Ultrasensitive Antibody Detection by Agglutination-PCR (ADAP)RHAMM (CD168) is overexpressed at the protein level and may constitute an immunogenic antigen in advanced prostate cancer disease.Antibody responses to prostate-associated antigens in patients with prostatitis and prostate cancerProfiling antibody responses by multiparametric analysis of primary B cells.Autoantibodies against p53 are associated with chromosome 17p deletions in chronic lymphocytic leukemia.Serum Autoantibodies in Chronic Prostate Inflammation in Prostate Cancer Patients.The ageing male reproductive tract.Targeting serum antibody for cancer diagnosis: a focus on colorectal cancer.Cancer immunomics using autoantibody signatures for biomarker discovery.Functions of normal and malignant prostatic stem/progenitor cells in tissue regeneration and cancer progression and novel targeting therapies.Identification of cancer autoantigens in serum: toward diagnostic/prognostic testing?Molecular biomarkers in prostate cancer.Autoantibodies to tumor-associated antigens as biomarkers in human hepatocellular carcinoma (HCC).Immunotherapy in prostate cancer: review of the current evidence.Personalized medicine for cancer therapy: Lessons learned from tumor-associated antigens.Cyclin B1 is commonly expressed in the cytoplasm of primary human acute myelogenous leukemia cells and serves as a leukemia-associated antigen associated with autoantibody response in a subset of patients.
P2860
Q28391166-8A4A2439-10FD-4888-964E-4EB5C06EBEC9Q33499385-F6831C91-13EE-4DBC-BE6A-640EC9BCE927Q34297813-22DC0E22-5B11-4852-B4EC-1BE93D991589Q34878648-8CE74EAE-0B98-4C71-978B-BE5A69D91BB9Q35049753-7831BA02-CDC7-459D-A9D1-BD14D885CCB7Q35919544-3F919909-E0C1-415A-A3C0-8C9693606750Q36698231-C66A83CD-8EFE-49F0-AB05-1ABCED2B99B9Q36709561-9D82EFD0-BDE1-42E2-8E09-DA927DEDD73BQ36766125-32751C7E-A64B-4ED5-8558-9B1656BF9FC1Q36860976-FF2106F1-F513-4ACF-BD57-EAE3FAD856C8Q37766224-32EB5544-190A-4D2B-871E-D3C6632DCA6EQ38088854-5AE767B3-B0AE-4480-85CA-B7DE2D5C2BDFQ38107971-CAD59F5D-4469-4B23-AFB7-76E3444AC39FQ38283918-7D0C3587-D0B2-4701-950E-46C1E2D56754Q40724853-CC8855B6-E7DE-4190-8B8A-7053464EC6C5Q53538160-E5F22693-8ED5-42C0-B49B-D5F19472F72A
P2860
Cancer immunomics: using autoantibody signatures in the early detection of prostate cancer.
description
2006 nî lūn-bûn
@nan
2006 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2006 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
name
Cancer immunomics: using autoa ...... detection of prostate cancer.
@ast
Cancer immunomics: using autoa ...... detection of prostate cancer.
@en
type
label
Cancer immunomics: using autoa ...... detection of prostate cancer.
@ast
Cancer immunomics: using autoa ...... detection of prostate cancer.
@en
prefLabel
Cancer immunomics: using autoa ...... detection of prostate cancer.
@ast
Cancer immunomics: using autoa ...... detection of prostate cancer.
@en
P2093
P1433
P1476
Cancer immunomics: using autoa ...... detection of prostate cancer.
@en
P2093
Arul M Chinnaiyan
Timothy J Bradford
Xiaoju Wang
P304
P356
10.1016/J.UROLONC.2005.11.033
P577
2006-05-01T00:00:00Z